Evidence map›Paper›PMID 31122271›Full record

ArticleJournal for immunotherapy of cancer2019

Correction to: Vaccination with nanoparticles combined with micro-adjuvants protects against cancer.

Mona O Mohsen, Matthew D Heath, Gustavo Cabral-Miranda, Cyrill Lipp, Andris Zeltins, Marcos Sande, Jens V Stein, Carsten Riether, Elisa Roesti, Lisha Zha and 9 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal for immunotherapy of cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Virus-like particle vaccinology, from bench to bedside.Cellular & molecular immunology · 2022
    Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 9 institutions in 6 countries.

Mona O MohsenJenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK. Mona.mohsen@dbmr.unibe.ch.
Matthew D HeathBencard Adjuvant Systems, Dominion Way, Worthing, UK.
Gustavo Cabral-MirandaDepartment of BioMedical Research, Immunology RIA, Inselspital, University of Bern, Bern, Switzerland.
Cyrill LippDepartment of BioMedical Research, Immunology RIA, Inselspital, University of Bern, Bern, Switzerland.
Andris ZeltinsLatvian Biomedical Research & Study Centre, Riga, Latvia.
Marcos SandeInstitute of anatomy, University of Bern, Bern, Switzerland.
Jens V SteinTheodor Kocher Institute, University of Bern, Bern, Switzerland.
Carsten RietherDepartment of Medical Oncology, Bern University Hospital, University of Bern, Bern, Switzerland.
Elisa RoestiDepartment of BioMedical Research, Immunology RIA, Inselspital, University of Bern, Bern, Switzerland.
Lisha ZhaDepartment of BioMedical Research, Immunology RIA, Inselspital, University of Bern, Bern, Switzerland.
Paul EngeroffDepartment of BioMedical Research, Immunology RIA, Inselspital, University of Bern, Bern, Switzerland.
Aadil El-TurabiJenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Thomas M KundigDepartment of Dermatology, University of Zurich, Zurich, Switzerland.
Monique VogelDepartment of BioMedical Research, Immunology RIA, Inselspital, University of Bern, Bern, Switzerland.
Murray A SkinnerBencard Adjuvant Systems, Dominion Way, Worthing, UK.
Daniel E SpeiserDepartment of Oncology, University of Lausanne, Lausanne, Switzerland.
Alexander KnuthNational Center for Cancer Care & Research (NCCCR), Doha, State of Qatar.
Matthias F KramerBencard Adjuvant Systems, Dominion Way, Worthing, UK.
Martin F BachmannJenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
University Hospital of Bern · CHUniversity of Bern · CHDominion (United States) · USJenner Institute · GBLatvian Biomedical Research and Study Centre · LVNational Center for Cancer Care and Research · QAUniversity of Lausanne · CHUniversity of Oxford · GBUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following publication of the original article [1], the author reported an author's family name has been misspelled. Paul Engroff should be replace Paul Engeroff.Furthermore, there are two mistake in two affiliations: 9) Department of dermatology, University of Zurich, Bern, Switzerland and 10) Department of Oncology, University of Lausanne, Bern,Switzerland should be replace with 9) Department of dermatology, University of Zurich, Zurich, Switzerland.10) Department of Oncology, University of Lausanne, Lausanne, Switzerland.

Identifiers

PMID31122271
PMCPMC6532182
OpenAlexW2947332434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.